Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.

P Moriondo, P Travaglini, M Nissim

    The Journal of Clinical Endocrinology and Metabolism
    |April 1, 1985
    PubMed
    Summary

    Bromocriptine effectively treats some prolactin-secreting pituitary microadenomas, with effectiveness improving after prolonged use. Post-treatment prolactin levels remained significantly decreased, and pituitary hormone responses were modified.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chest Abdominal-Focused Assessment Sonography for Trauma during the primary survey in the Emergency Department: the CA-FAST protocol.

    European journal of trauma and emergency surgery : official publication of the European Trauma Society·2015
    Same author

    The adolescent patient: parental responsibility, the right to be informed and the right to be heard.

    Minerva stomatologica·2015
    Same author

    Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-TNF-α monoclonal antibody: an observational multicenter study.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2015
    Same author

    [Literature review and state of the art of the Italian law on medically assisted reproduction].

    La Clinica terapeutica·2015
    Same author

    Cardiorespiratory of land and water walking on a non motorized treadmill.

    The Journal of sports medicine and physical fitness·2015
    Same author

    Investigating psoriasis awareness among patients in Italy: validation of a questionnaire.

    European review for medical and pharmacological sciences·2014

    Area of Science:

    • Endocrinology
    • Neuroendocrinology
    • Pharmacology

    Background:

    • Prolactin-secreting pituitary microadenomas are a common endocrine disorder.
    • Bromocriptine is a dopamine agonist used for treating hyperprolactinemia.

    Purpose of the Study:

    • To evaluate the efficacy and long-term effects of bromocriptine in women with prolactinomas.
    • To assess changes in prolactin secretion and pituitary hormone responses after bromocriptine treatment.

    Main Methods:

    • Thirty-six women with pituitary microadenomas were treated with bromocriptine (2.5-10 mg/day) for 12 months.
    • Serum prolactin levels were monitored during and after treatment.
    • Responses to TRH and domperidone stimulation tests were assessed before and after bromocriptine administration.

    Related Experiment Videos

    Main Results:

    • Bromocriptine treatment led to a significant decrease in serum prolactin levels in all patients.
    • Patients were categorized into responders, hyporesponders, and nonresponders based on prolactin reduction.
    • Prolonged bromocriptine use improved treatment effectiveness, with some patients achieving remission.
    • Pituitary hormone responses to TRH and domperidone were altered, suggesting modifications in prolactin secretion regulation.

    Conclusions:

    • Bromocriptine is an effective treatment for a subset of patients with prolactin-secreting pituitary microadenomas.
    • Prolonged bromocriptine administration enhances its therapeutic efficacy.
    • Bromocriptine treatment induces significant changes in the regulation of prolactin secretion.